首页 › 基金 › Stonepine Capital Management, LLC › BMRN

Stonepine Capital Management, LLC 对 BMRN 的持仓历史

BIOMARIN PHARMACEUTICAL INC COM · 医疗保健

Stonepine Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC COM)50,000 股,市值约 US$3.1M,约占其申报组合的 2.07%,在其申报持仓中市值排名第 19 位。 Stonepine Capital Management, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)50.00K 股
申报持仓市值$3.12M
组合权重2.07%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Stonepine Capital Management, LLC 对 BMRN 的持仓演变

Stonepine Capital Management, LLC 于 Q2 2026 首次披露 BMRN 持仓:50,000 股(约 US$3.1M)。

逐季持仓明细

季度股数金额变化
Q2 2026 50.00K $3.12M 新进

关于 BMRN 与 13F 数据

BMRN(BIOMARIN PHARMACEUTICAL INC COM)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BMRN 的基金

查看 BMRN 的全部基金持有人 →

常见问题

How long has Stonepine Capital Management, LLC held BMRN?

Stonepine Capital Management, LLC has disclosed BMRN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Stonepine Capital Management, LLC's current position in BMRN?

As of Q2 2026, Stonepine Capital Management, LLC holds 50.00K shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $3.12M, representing 2.07% of its reported portfolio and ranking #19.

Has Stonepine Capital Management, LLC been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Stonepine Capital Management, LLC newly opened its position in BMRN.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.